DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Anti-inflammatory are 13




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_0608Carprofen
Anti-inflammatory
Joint pain
Lassa virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (50 %)
Approved, Withdrawn
23577127
DrugRepV_0631Carprofen
Anti-inflammatory
Joint pain
Lassa virus
Josiah
NA
Real-time PCR
No significant effect
Approved, Withdrawn
23577127
DrugRepV_0647Carprofen
Anti-inflammatory
Joint pain
Marburg virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (88 %)
Approved, Withdrawn
23577127
DrugRepV_0671Carprofen
Anti-inflammatory
Joint pain
Ebola virus
GP derived Pseudovirus
NA
Luciferase reporter assay
Decrease (94 %)
Approved, Withdrawn
23577127
DrugRepV_0694Carprofen
Anti-inflammatory
Joint pain
Ebola virus
EBOLA-eGFP
NA
Fluorescence-based assay
No significant effect
Approved, Withdrawn
23577127
DrugRepV_2083JNJ7777120
Anti-inflammatory
Pruritus (itching)
Ebola virus
HIV/EBOV
NA
Luciferase reporter assay
Decrease (50 %)
NA
29981374
DrugRepV_2084JNJ7777120
Anti-inflammatory
Pruritus (itching)
Marburg virus
HIV/MARV
NA
Luciferase reporter assay
Decrease (50 %)
NA
29981374
DrugRepV_2159Flunixin Meglumin
Anti-inflammatory
Anti-inflammatory agent (used in animals)
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Decrease (57.8934305 %)
NA
27742486
DrugRepV_2204Dimethyl Fumarate
Anti-inflammatory
Multiple sclerosis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (8.81629076 %)
Approved
27742486
DrugRepV_5671Epoxomicin
Anti-inflammatory
Hypertension
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
26565697
DrugRepV_5672Epoxomicin
Anti-inflammatory
Hypertension
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
26565697
DrugRepV_5673Epoxomicin
Anti-inflammatory
Hypertension
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
26565697
DrugRepV_5674Epoxomicin
Anti-inflammatory
Hypertension
Dengue virus
NA
Pathway
Plaque assay
Decrease (50 %)
NA
26565697